Interaction of MTHFR polymorphism with PAX1 methylation in cervical cancer

MTHFR多态性与PAX1甲基化在宫颈癌中的相互作用

阅读:2

Abstract

We aimed to investigate the roles and interaction effects of high-risk human papillomavirus (HR-HPV) infection, methyltetrahydrofolate reductase (MTHFR) polymorphism, and paired box gene 1 (PAX1) methylation in cervical intraepithelial neoplasia (CIN) and cervical cancer. Polymerase chain reaction was used to detect MTHFR polymorphism and PAX1 methylation; Mantel-Haenszel and Spearman's rank correlation tests were used to analyze the trends and correlations. Forty cases each of normal control (NC), CIN I, and CIN II/III and 9 squamous cell carcinoma (SCC) cases were enrolled. Increase in age increases the risk of cervical cancer. The HR-HPV infection rate, MTHFR mutation rate, and PAX1 methylation rate in CIN I, CIN II/III, and SCC groups were significantly higher than those in the NC group (P < 0.05). The above-mentioned rates gradually increased with the degree of cervical lesions. Moreover, HR-HPV infection, MTHFR polymorphism, and PAX1 methylation increased the risk of both CIN and cancer. A positive additive interaction was observed between PAX1 methylation and MTHFR polymorphism across different cervical lesion groups, whereas no interaction was found between HR-HPV infection and PAX1 methylation in lesion progression.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。